...
首页> 外文期刊>European journal of ophthalmology >The role of pars plana vitrectomy in the diagnosis and treatment of uveitis.
【24h】

The role of pars plana vitrectomy in the diagnosis and treatment of uveitis.

机译:平板玻璃体切除术在葡萄膜炎的诊断和治疗中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To assess the diagnostic yield of vitreous fluid analysis and the therapeutic effect of pars plana vitrectomy in patients with suspected intraocular inflammation. METHODS: During 2004-2008, pars plana vitrectomy was performed in 89 patients (101 eyes) out of 1233 patients with uveitis. Vitreous specimens were analyzed by cytologic and histopathologic examination, microbiologic culture, polymerase chain reaction, antibody determination, and flow cytometry. Vitrectomy was performed in 85 eyes for both diagnostic and therapeutic purposes; the remaining 16 eyes underwent only diagnostic pars plana vitrectomy. Preoperative and postoperative best-corrected Snellen visual acuity was compared. RESULTS: Preoperative diagnoses were infection in 40 patients, malignant masquerade syndrome in 10 patients, and idiopathic uveitis in 39 patients. Vitreous analysis contributed to the determination of diagnosis in 54 patients (61%). Final diagnoses were infection in 42 patients, malignant masquerade syndrome in 6 patients, benign masquerade syndrome in 16 patients, and idiopathic uveitis in 25 patients. Vitreous fluid collected from each eye underwent approximately 2.2 (range 1-6) laboratory tests. Therapeutic reasons for vitrectomy were the treatment of complications of uveitis in 42 eyes and/or intravitreal application of anti-infectious or cytostatic drugs in 49 eyes. Overall, the visual acuity improved in 45% of eyes, remained unchanged in 45% of eyes, and decreased in 10% of eyes in 3 months after surgery. CONCLUSIONS: Pars plana vitrectomy with carefully selected testing is a valuable tool for assessment of diagnosis in a large proportion of patients with uveitis. Moreover, the therapeutic effect of vitrectomy can improve the visual outcomes in these patients.
机译:目的:评估玻璃体液分析在怀疑眼内炎症患者中的诊断率以及平板玻璃体切除术的治疗效果。方法:在2004年至2008年期间,对1233例葡萄膜炎患者中的89例(101眼)进行了平视玻璃体切除术。通过细胞学和组织病理学检查,微生物培养,聚合酶链反应,抗体测定和流式细胞术对玻璃体标本进行了分析。玻璃体切除术用于诊断和治疗目的的85只眼。其余16只眼睛仅接受了诊断性的平板玻璃体切除术。比较术前和术后最佳矫正Snellen视力。结果:术前诊断为感染40例,恶性化装综合症10例,特发性葡萄膜炎39例。玻璃体分析有助于确诊54例患者(61%)。最终诊断为感染42例,恶性化装综合症6例,良性化装综合症16例,特发性葡萄膜炎25例。从每只眼睛收集的玻璃体液接受了大约2.2(1-6范围)的实验室测试。玻璃体切除术的治疗原因是治疗葡萄膜炎42眼和/或玻璃体内应用抗感染或抑制细胞生长的药物49眼。总体而言,术后3个月,视力改善了45%的眼睛,保持了45%的眼睛不变,而视力下降了10%。结论:经精心选择的检查方法可将扁平玻璃体玻璃体切除术是评估大部分葡萄膜炎患者诊断的有价值的工具。此外,玻璃体切割术的治疗效果可以改善这些患者的视觉效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号